Earnings NewsHealthcareAvanir Pharmaceuticals misses by $0.01, misses on revenueMay 06, 2014 4:14 PM ETAvanir Pharmaceuticals, Inc (AVNR) StockBy: Mohit Manghnani, SA News Editor Avanir Pharmaceuticals (NASDAQ:AVNR): FQ2 EPS of -$0.08 misses by $0.01. Revenue of $26.9M (+54.3% Y/Y) misses by $1.31M. Press Release Recommended For YouMore Trending NewsSee More »Related StocksSymbolLast Price% ChgAVNR--Avanir Pharmaceuticals, IncTrending AnalysisTrending News